| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0508 |
| Document Type: 4/A |
| Period of Report: 3/12/24 |
| Date of Original Submission: 3/12/24 |
| Issuer: |
| Issuer CIK: 1341235 |
| Issuer Name: Aldeyra Therapeutics, Inc. |
| Issuer Trading Symbol: ALDX |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1836354 |
| | Owner Name: Machatha Stephen |
| Reporting Owner Address: |
| | Owner Street 1: C/O ALDEYRA THERAPEUTICS, INC. |
| | Owner Street 2: 131 HARTWELL AVENUE |
| | Owner City: LEXINGTON |
| | Owner State: MA |
| | Owner ZIP Code: 02421 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: Chief Development Officer |
| Aff 10b5 One? No |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 3/12/24 |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: S |
| | | Equity Swap Involved? No |
| | | Footnote ID: F1 |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 11,537 |
| | | Transaction Price Per Share: |
| Value: 3.164 |
| Footnote ID: F2 |
| | | Transaction Acquired-Disposed Code: |
| Value: D |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 252,812 |
| Footnote ID: F3 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: These shares of common stock were sold by the Reporting Person for tax withholding and tax planning purposes in connection with the settlement of certain time-based restricted stock unit awards. This sale was previously reported in the Reporting Person's Form 4 filed on March 12, 2024 (the "Original Form 4"). |
| Footnote - F2: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.31. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| Footnote - F3: Adjusted to reflect 9,317 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan, which were inadvertently omitted in the Original Form 4. The amount in Column 5 of this Form 4 reflects the number of shares beneficially owned by the Reporting Person as of the date of this report after giving effect to the adjustment. |
| Owner Signature: |
| Signature Name: /s/ Stephen Machatha |
| Signature Date: 4/17/24 |
